Skip to main content
Piramal Pharma Limited (NSE:PPLPHARMA)
India flag India · Delayed Price · Currency is INR
163.75
-0.72 (-0.44%)
Apr 29, 2026, 10:50 AM IST

Piramal Pharma Revenue

Piramal Pharma had revenue of 21.40B INR in the quarter ending December 31, 2025, a decrease of -2.92%. This brings the company's revenue in the last twelve months to 88.71B, down -0.87% year-over-year. In the fiscal year ending March 31, 2025, Piramal Pharma had annual revenue of 91.51B with 11.99% growth.

Revenue (ttm)
88.71B
Revenue Growth
-0.87%
P/S Ratio
2.46
Revenue / Employee
16.20M
Employees
5,476
Market Cap
218.39B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 202591.51B9.80B11.99%
Mar 31, 202481.71B10.90B15.39%
Mar 31, 202370.82B3.47B5.16%
Mar 31, 202267.34B8.47B14.39%
Mar 31, 202158.87B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Wockhardt 31.74B
NATCO Pharma 45.63B
Eris Lifesciences 30.65B
Gland Pharma 61.13B
Emcure Pharmaceuticals 88.50B
Alembic Pharmaceuticals 72.67B
Ajanta Pharma 52.02B
Cohance Lifesciences 10.79B
Revenue Rankings

Piramal Pharma News

More News